Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > 2nd phase III was already run for "SAFETY"....
View:
Post by somweyungguy on Nov 03, 2015 10:34pm

2nd phase III was already run for "SAFETY"....

OH they're sly "NoHump"....

The "ENDO Experience" was beneficial on MANY levels...

Most importantly it added significant numbers to the existing 129 from the first phase III so the FDA could easily put the "Elmer the Safety Elephant" safety seal on this little puppy.

Ah the ENDO phase III...."purrrrrrrfect"

Sqr

PS - MCNA sends ENDO from $80 to $130?? or BNC from .14 to $5 - take yur pick
Comment by somweyungguy on Nov 04, 2015 8:34am
How many "patient experiences" were there in the failed ENDO phase III trial? 60, 80, 120, 140?? We were delivered two damaging NR's around this trial...how many patients added to our SAFETY PROFILE?? It looks like a lot of money was spent and it would seem that the FDA had their eye on the safety experience the whole time...the trial was stopped because of enrolment NOT because ...more  
Comment by sprules on Nov 04, 2015 8:51am
87 I believe.
Comment by rgonlyfactspls on Nov 04, 2015 9:03am
Release the hounds!!! Good to hear from you again
Comment by somweyungguy on Nov 04, 2015 11:10am
RE:2nd phase III was already run for "SAFETY".... How many "patient experiences" were there in the failed ENDO phase III trial? 60, 80, 120, 140?? We were delivered two damaging NR's around this trial...how many patients added to our SAFETY PROFILE?? It looks like a lot of money was spent and it would seem that the FDA had their eye on the safety experience the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities